Trial intelligence / Profile preview

Dexmedetomidine-based ERAS in Cardiac Surgery

NCT06907277Completed

Sponsor
Benha University
Start
Aug 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in postoperative delirium (POD), postoperative pain and sleep disorder (2 arms), sponsored by Benha University. Primary endpoint: Significant Enhancement of Post Operative Recovery Levels After Dexmedetomidine Administration in Cardiac Surgery at 3 months. Started Aug 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)postoperative painsleep disorder

Beyond the preview

Go deeper on NCT06907277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06907277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call